Albert David Limited — Others, 02-08-2025: Change in Management

The company's board has approved the financial results for the quarter. A key development is the appointment of Dr. Rajiv Anant Desai as an Additional Non-Executive Independent Director for five years, effective August 2, 2025. This decision followed a review by the Nomination and Remuneration Committee and awaits shareholder approval via a postal ballot. Dr. Desai brings over 38 years of extensive experience in the pharmaceutical industry, including senior roles at Lupin Limited and an advisory role with the Indian Pharmaceutical Alliance, enhancing the board's expertise.